Cyanide Toxicity Workup
- Author: Inna Leybell, MD; Chief Editor: Asim Tarabar, MD more...
The workup in patients with cyanide exposure may include the studies discussed below.
Arterial and venous blood gases
Cyanide toxicity is characterized by a normal arterial oxygen tension and an abnormally high venous oxygen tension, resulting in a decreased arteriovenous oxygen difference (< 10%). A high-anion-gap metabolic acidosis is a hallmark of significant cyanide toxicity.[7, 19] Apnea may result in combined metabolic and respiratory acidosis.
Blood lactate level
Elevation in the blood lactate level is a sensitive marker for cyanide toxicity. A plasma lactate concentration of greater than 10 mmol/L in smoke inhalation or greater than 6 mmol/L after reported or strongly suspected pure cyanide poisoning suggests significant cyanide exposure.
Red blood cell or plasma cyanide concentration
Cyanide blood concentrations are not generally available in time to aid in the treatment of acute poisoning, but may provide subsequent confirmation. In cyanogen exposures, these tests provide documentation for therapeutic use, which may last several days.
The preferred test is a red blood cell cyanide concentration. With this method, mild toxicity is observed at concentrations of 0.5-1.0 μg/mL. Concentrations of 2.5 μg/mL and higher are associated with coma, seizures, and death. Blood cyanide concentrations may artificially increase after sodium nitrite (antidote) administration, because of in vitro release of cyanide from cyanomethemoglobin during the analytical procedure by strong acid used in analysis.
Carboxyhemoglobin level or blood carbon monoxide concentration
Carboxyhemoglobin (HbCO) level (by co-oximetry) or blood carbon monoxide concentration (by infrared spectroscopy) may be obtained in patients with smoke inhalation to rule out concurrent exposure. HbCO measurements may be artificially elevated in blood samples drawn after hydroxocobalamin administration.
A methemoglobin level is especially important in cyanotic patients. The presence of methemoglobin suggests that little or no free cyanide is available for binding, because methemoglobin vigorously binds cyanide to form cyanomethemoglobin (which is not measured as methemoglobin).
Methemoglobin concentrations provide a guide for continued therapy after the use of methemoglobin-inducing antidotes, such as sodium nitrite. Elevated levels of methemoglobin (>10%) indicate that further nitrite therapy is not indicated and, in fact, may be dangerous.
On ECG, nonspecific findings predominate. Abnormalities may include the following :
Sinus bradycardia or tachycardia
Supraventricular or ventricular arrhythmias
Ischemic electrocardiographic changes
In some cases, shortening of the ST segment with eventual fusion of the T wave into the QRS complex has been observed.
No imaging studies are indicated acutely for cyanide exposure, but magnetic resonance imaging (MRI) may be useful during the evaluation of postexposure neurologic sequelae.
Fluorescein staining and slit-lamp examination of the eyes may be necessary following decontamination to assess corneal integrity.
Armstrong J. Chemical warfare. RN. 2002 Apr. 65(4):32-9; quiz 40. [Medline].
Brennan RJ, Waeckerle JF, Sharp TW, Lillibridge SR. Chemical warfare agents: emergency medical and emergency public health issues. Ann Emerg Med. 1999 Aug. 34(2):191-204. [Medline].
Akyildiz BN, Kurtoglu S, Kondolot M, Tunc A. Cyanide poisoning caused by ingestion of apricot seeds. Ann Trop Paediatr. 2010. 30(1):39-43. [Medline].
Baud FJ. Cyanide: critical issues in diagnosis and treatment. Hum Exp Toxicol. 2007 Mar. 26(3):191-201. [Medline].
Greenfield RA, Brown BR, Hutchins JB, Iandolo JJ, Jackson R, Slater LN, et al. Microbiological, biological, and chemical weapons of warfare and terrorism. Am J Med Sci. 2002 Jun. 323(6):326-40. [Medline].
Rosenbloom M, Leikin JB, Vogel SN, Chaudry ZA. Biological and chemical agents: a brief synopsis. Am J Ther. 2002 Jan-Feb. 9(1):5-14. [Medline].
Baskin SI, Brewer TG. Cyanide poisoning. Cyanide poisoning. Medical Aspects of Chemical and Biological Warfare. 1997. 271-286.
Morocco AP. Cyanides. Crit Care Clin. 2005 Oct. 21(4):691-705, vi. [Medline].
Sidell FR, Patrick WC, Dashiell TR. Cyanide. Jane's Chem-Bio Handbook. 1998. 79-88.
USACHPPM. Cyanide. USACHPPM Tech Guide 244: The Medical NBC Battlebook. 1999. V: 36-37.
Burda AM, Sigg T. Pharmacy preparedness for incidents involving weapons of mass destruction. Am J Health Syst Pharm. 2001 Dec 1. 58(23):2274-84. [Medline].
Lynch EL, Thomas TL. Pediatric considerations in chemical exposures: are we prepared?. Pediatr Emerg Care. 2004 Mar. 20(3):198-208. [Medline].
Zheng A, Dzombak DA, Luthy RG. Formation of free cyanide and cyanogen chloride from chloramination of publicly owned treatment works secondary effluent: laboratory study with model compounds. Water Environ Res. 2004 Mar-Apr. 76(2):113-20. [Medline].
Schnepp R. Cyanide: sources, perceptions, and risks. J Emerg Nurs. 2006 Aug. 32(4 Suppl):S3-7. [Medline].
Musshoff F, Schmidt P, Daldrup T, Madea B. Cyanide fatalities: case studies of four suicides and one homicide. Am J Forensic Med Pathol. 2002 Dec. 23(4):315-20. [Medline].
National Cancer Institute. Cancer topics: Laetrile/Amygdalin. 11/21/2005. [Full Text].
Mowry JB, Spyker DA, Brooks DE, McMillan N, Schauben JL. 2014 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 32nd Annual Report. Clin Toxicol (Phila). 2015 Dec. 53 (10):962-1147. [Medline]. [Full Text].
Department of the Army. Blood agents (Cyanogens). Field Manual 8-285: Treatment of Chemical Agent Casualties and Conventional Military Chemical Injuries. 1995. VI: 1-2.
Baud FJ, Borron SW, Mégarbane B, Trout H, Lapostolle F, Vicaut E, et al. Value of lactic acidosis in the assessment of the severity of acute cyanide poisoning. Crit Care Med. 2002 Sep. 30(9):2044-50. [Medline].
Baud FJ, Barriot P, Toffis V, Riou B, Vicaut E, Lecarpentier Y, et al. Elevated blood cyanide concentrations in victims of smoke inhalation. N Engl J Med. 1991 Dec 19. 325(25):1761-6. [Medline].
Lee J, Mukai D, Kreuter K, et al. Potential interference by hydroxocobalamin on co-oximetry hemoglobin measurements during cyanide and smoke inhalation treatments. Ann Emerg Med. 2007. 49(6):802-805. [Medline].
Fortin JL, Desmettre T, Manzon C, Judic-Peureux V, Peugeot-Mortier C, Giocanti JP, et al. Cyanide poisoning and cardiac disorders: 161 cases. J Emerg Med. 2010 May. 38(4):467-76. [Medline].
USAMRICD. Cyanide. Field Management of Chemical Casualties Handbook. 1996. 37-40.
USAMRICD. Cyanide. Medical Management of Chemical Casualties Handbook. 1999. 38-58.
Martin CO, Adams HP Jr. Neurological aspects of biological and chemical terrorism: a review for neurologists. Arch Neurol. 2003 Jan. 60(1):21-5. [Medline].
Kirk MA, Gerace R, Kulig KW. Cyanide and methemoglobin kinetics in smoke inhalation victims treated with the cyanide antidote kit. Ann Emerg Med. 1993 Sep. 22(9):1413-8. [Medline].
Borron SW, Baud FJ, Mégarbane B, Bismuth C. Hydroxocobalamin for severe acute cyanide poisoning by ingestion or inhalation. Am J Emerg Med. 2007 Jun. 25(5):551-8. [Medline].
Borron SW, Baud FJ, Barriot P, Imbert M, Bismuth C. Prospective study of hydroxocobalamin for acute cyanide poisoning in smoke inhalation. Ann Emerg Med. 2007 Jun. 49(6):794-801, 801.e1-2. [Medline].
DesLauriers CA, Burda AM, Wahl M. Hydroxocobalamin as a cyanide antidote. Am J Ther. 2006 Mar-Apr. 13(2):161-5. [Medline].
Hall AH, Saiers J, Baud F. Which cyanide antidote?. Crit Rev Toxicol. 2009. 39(7):541-52. [Medline].
Curry SC, Connor DA, Raschke RA. Effect of the cyanide antidote hydroxocobalamin on commonly ordered serum chemistry studies. Ann Emerg Med. 1994 Jul. 24(1):65-7. [Medline].
Sutter M, Tereshchenko N, Rafii R, Daubert GP. Hemodialysis Complications of Hydroxocobalamin: A Case Report. J Med Toxicol. 2010 Mar 30. [Medline].
Shepherd G, Velez LI. Role of hydroxocobalamin in acute cyanide poisoning. Ann Pharmacother. 2008 May. 42(5):661-9. [Medline].